Omega Healthcare Investors (NYSE:OHI) had its price target lowered by research analysts at Wells Fargo & Co from $43.00 to $28.00 in a research note issued to investors on Thursday, BenzingaRatingsTable reports. The brokerage presently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Co‘s price objective suggests a potential upside of 2.87% from the stock’s current price.
OHI has been the topic of several other research reports. Mizuho started coverage on shares of Omega Healthcare Investors in a research report on Thursday, December 19th. They set a “buy” rating and a $50.00 target price on the stock. Citigroup started coverage on shares of Omega Healthcare Investors in a research report on Wednesday, January 22nd. They set a “neutral” rating and a $44.00 target price on the stock. Bank of America cut shares of Omega Healthcare Investors from a “buy” rating to a “neutral” rating in a research report on Monday. Zacks Investment Research cut shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research report on Tuesday, March 17th. Finally, Raymond James raised shares of Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $30.00 target price on the stock in a research report on Wednesday. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $40.79.
Shares of Omega Healthcare Investors stock traded up $1.11 during mid-day trading on Thursday, hitting $27.22. 408,250 shares of the stock were exchanged, compared to its average volume of 4,169,935. Omega Healthcare Investors has a 12 month low of $13.33 and a 12 month high of $45.22. The company has a 50-day simple moving average of $36.82 and a 200 day simple moving average of $40.87. The company has a debt-to-equity ratio of 1.18, a quick ratio of 2.67 and a current ratio of 2.67. The company has a market capitalization of $5.72 billion, a P/E ratio of 17.23, a P/E/G ratio of 3.86 and a beta of 0.49.
Omega Healthcare Investors (NYSE:OHI) last posted its earnings results on Wednesday, February 5th. The real estate investment trust reported $0.27 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.37 by ($0.10). Omega Healthcare Investors had a return on equity of 8.38% and a net margin of 36.73%. The firm had revenue of $212.18 million for the quarter, compared to the consensus estimate of $204.40 million. During the same period in the prior year, the business earned $0.73 EPS. Omega Healthcare Investors’s quarterly revenue was up 12.7% compared to the same quarter last year. Analysts predict that Omega Healthcare Investors will post 3.13 EPS for the current year.
In other Omega Healthcare Investors news, insider Steven J. Insoft sold 50,000 shares of the business’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $44.00, for a total transaction of $2,200,000.00. Following the sale, the insider now owns 183,032 shares of the company’s stock, valued at approximately $8,053,408. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Craig R. Callen bought 5,000 shares of the stock in a transaction on Monday, March 16th. The shares were acquired at an average cost of $17.68 per share, for a total transaction of $88,400.00. Insiders sold a total of 150,000 shares of company stock worth $6,480,500 in the last ninety days. 1.16% of the stock is currently owned by insiders.
A number of hedge funds have recently modified their holdings of the business. Huntington National Bank bought a new position in shares of Omega Healthcare Investors during the fourth quarter valued at about $27,000. FSA Wealth Management LLC bought a new position in shares of Omega Healthcare Investors during the fourth quarter valued at about $32,000. FTB Advisors Inc. raised its stake in shares of Omega Healthcare Investors by 48.4% during the fourth quarter. FTB Advisors Inc. now owns 766 shares of the real estate investment trust’s stock valued at $32,000 after acquiring an additional 250 shares during the last quarter. Archer Investment Corp bought a new position in shares of Omega Healthcare Investors during the fourth quarter valued at about $34,000. Finally, Arlington Partners LLC bought a new position in shares of Omega Healthcare Investors during the fourth quarter valued at about $38,000. 74.46% of the stock is currently owned by institutional investors and hedge funds.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Featured Article: Stock Symbols and CUSIP Explained
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.